29 August 2008

Tetrabenazine approved for Huntington's

Tetrabenazine, available for decades in Europe, has been approved by the FDA for treatment of Huntington's disease. Tetrabenazine is symptomatic treatment of the chorea; it is not expected to alter the disease course.

Brad Evans